ACADIA Pharmaceuticals(ACAD) - 2023 Q4 - Earnings Call Transcript

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Q4 2023 Earnings Conference Call February 27, 2024 4:30 PM ET Company Participants Al Kildani - Senior Vice President, Investor Relations and Corporate Communications Steve Davis - President and Chief Executive Officer Brendan Teehan - Executive Vice President, Chief Operating Officer, Head of Commercial Doug Williamson - Executive Vice President, Head of Research and Development Mark Schneyer - Executive Vice President, Chief Financial Officer Parag Meswani - Senio ...